Skip header and navigation

Narrow By

   MORE

11 records – page 1 of 1.

Hospital Pharmacy Services

https://libcat.nshealth.ca/en/permalink/chpams35418
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1501
Available Online
View Pamphlet
The hospital Pharmacy Department includes pharmacists and pharmacy practice assistants, who are important members of your health care team. They offer medication knowledge and care in all areas of Nova Scotia Health Authority (NSHA). This pamphlet describes services offered such as: medical preparation, medication history, medication management, medication teaching, health promotion, learning, teaching, and research, and medication information and review. The French version of this pamphlet 210…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Pharmacy Service, Hospital
Pharmaceutical Services
Subjects (LCSH)
Hospital pharmacies
Pharmaceutical services
Abstract
The hospital Pharmacy Department includes pharmacists and pharmacy practice assistants, who are important members of your health care team. They offer medication knowledge and care in all areas of Nova Scotia Health Authority (NSHA). This pamphlet describes services offered such as: medical preparation, medication history, medication management, medication teaching, health promotion, learning, teaching, and research, and medication information and review. The French version of this pamphlet 2108, "Services de pharmacie d’hôpital", is also available.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1501
Less detail
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
0373
Available Online
View Pamphlet
This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Alternate Title
Coumadin
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Warfarin
Anticoagulants
Subjects (LCSH)
Warfarin
Anticoagulants (Medicine)
Abstract
This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and food interactions, side effects, and safety precautions are provided. Contact numbers are also given if you have questions. The French translation of this pamphlet 2063, "Warfarine sodique" is also available.
Notes
Previous title: Warfarin sodium, an oral anticoagulant
Responsibility
Prepared by: Pharmacy Services ; Revised by: Hematology Services, QEII
Pamphlet Number
0373
Less detail

Warfarine sodique

https://libcat.nshealth.ca/en/permalink/chpams36661
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2063
Available Online
View Pamphlet
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également f…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Alternate Title
Coumadin
Warfarin sodium
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Warfarin
Anticoagulants
Subjects (LCSH)
Warfarin
Anticoagulants (Medicine)
Abstract
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également fournies sur la façon de prendre le médicament, les doses manquées, les analyses sanguines RIN (ou INR), les interactions médicamenteuses et alimentaires, les effets secondaires et les mesures de sécurité. Vous y trouverez aussi des numéros où appeler si vous avez des questions.
This is a French translation of the English pamphlet 0373 “Warfarin Sodium". This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and food interactions, side effects, and safety precautions are provided. Contact numbers are also given if you have questions.
Responsibility
Prepared by: Pharmacy Services ; Revised by: Hematology Services, QEII
Pamphlet Number
2063
Less detail

Services de pharmacie d’hôpital

https://libcat.nshealth.ca/en/permalink/chpams36739
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2108
Available Online
View Pamphlet
Les Services de pharmacie d’hôpital comptent des pharmaciens et des assistants en pharmacie, qui sont des membres importants de votre équipe de soins de santé. Grâce à leurs connaissances sur les médicaments, ils offrent des soins dans tous les secteurs de la Régie de la santé de la Nouvelle-Écosse (la Régie). La brochure décrit les services offerts, dont la préparation des médicaments, les antécédents pharmaceutiques, la gestion de la pharmacothérapie, les renseignements sur les médicaments, l…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Alternate Title
Hospital pharmacy services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Pharmacy Service, Hospital
Pharmaceutical Services
Subjects (LCSH)
Hospital pharmacies
Pharmaceutical services
Specialty
Medications
Abstract
Les Services de pharmacie d’hôpital comptent des pharmaciens et des assistants en pharmacie, qui sont des membres importants de votre équipe de soins de santé. Grâce à leurs connaissances sur les médicaments, ils offrent des soins dans tous les secteurs de la Régie de la santé de la Nouvelle-Écosse (la Régie). La brochure décrit les services offerts, dont la préparation des médicaments, les antécédents pharmaceutiques, la gestion de la pharmacothérapie, les renseignements sur les médicaments, la promotion de la santé, l’apprentissage, l’enseignement et la recherche, l’information et l’examen des médicaments.
This pamphlet is a French translation of "Hospital Pharmacy Services" pamphlet 1501. The hospital Pharmacy Department includes pharmacists and pharmacy practice assistants, who are important members of your health care team. They offer medication knowledge and care in all areas of Nova Scotia Health Authority (NSHA). This pamphlet describes services offered such as: medical preparation, medication history, medication management, medication teaching, health promotion, learning, teaching, and research, and medication information and review.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
2108
Less detail

Bowel preparation for chronic kidney disease before colonoscopy

https://libcat.nshealth.ca/en/permalink/chpams35387
Nova Scotia Health Authority. Renal Program, Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1475
Available Online
View Pamphlet
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cathartics
Colonoscopy
Renal Insufficiency, Chronic
Subjects (LCSH)
Laxatives
Colonoscopy
Chronic renal failure
Specialty
Medications
Nephrology
Abstract
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
Responsibility
Prepared by: NSHA Renal Program Educators and Pharmacists
Pamphlet Number
1475
Less detail

Rocaltrol® (calcitriol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36671
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1468
Available Online
View Pamphlet
Rocaltrol® is a medicine that contains the active ingredient calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause low levels of calcium in the blood and bone problems. This medicine skips the …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Calcitriol
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
Rocaltrol® is a medicine that contains the active ingredient calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause low levels of calcium in the blood and bone problems. This medicine skips the step done by the kidneys and increases the amount of vitamin D in your body that can be used. How to take the medicine and what side effects to watch for are reviewed. Rocaltrol® is a brand name for calcitriol.
Responsibility
Prepared by: Renal Pharmacy Team, NSHA Renal Program
Pamphlet Number
1468
Less detail

One-Alpha® (alfacalcidol) and hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams36672
Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1470
Available Online
View Pamphlet
One-Alpha® is a medicine that contains the active ingredient alfacalcidol, which is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Insufficiency, Chronic - drug therapy
Renal Dialysis
Subjects (LCSH)
Chronic renal failure
Kidneys--Diseases--Treatment
Hemodialysis
Abstract
One-Alpha® is a medicine that contains the active ingredient alfacalcidol, which is a form of vitamin D. The liver changes alfacalcidol to calcitriol, which is a form of vitamin D that can be used by the body. It acts as a hormone in your body to control the levels of calcium and phosphate, which are needed to build healthy bone. People with kidney disease cannot change enough vitamin D into calcitriol. We get vitamin D from sunlight, and from eating oily fish and milk products. This can cause low levels of calcium in the blood and bone problems. This medicine skips the step done by the kidneys and increases the amount of vitamin D in your body that can be used. How to take the medicine and what side effects to watch for are reviewed. One-Alpha® is a brand name for alfacalcidol.
Responsibility
Prepared by: Renal Pharmacy Team, NSHA Renal Program
Pamphlet Number
1470
Less detail

How to use nicotine replacement therapy (NRT)

https://libcat.nshealth.ca/en/permalink/chpams35482
Nova Scotia Health Authority. Mental Health and Addictions, Nova Scotia Health Authority. Respiratory Therapy Services, Nova Scotia Health Authority. Pharmacy Services, Nova Scotia Health Authority. Occupational Health Safety and Wellness. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
2145
Available Online
View Pamphlet
Nova Scotia Health promotes a smoke-free, tobacco-free, and vape-free environment for patients, visitors, and staff. Nova Scotia Health is committed to helping people smoke less, stop smoking, and stay smoke-free. This pamphlet provides information about nicotine replacement therapy options such as the nicotine patch, nicotine gum, nicotine lozenges, and nicotine inhaler.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Mental Health and Addictions
Nova Scotia Health Authority. Respiratory Therapy Services
Nova Scotia Health Authority. Pharmacy Services
Nova Scotia Health Authority. Occupational Health Safety and Wellness
Alternate Title
How to use NRT
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Smoking Cessation
Tobacco Use Cessation Devices
Subjects (LCSH)
Smoking cessation
Smoking cessation products
Abstract
Nova Scotia Health promotes a smoke-free, tobacco-free, and vape-free environment for patients, visitors, and staff. Nova Scotia Health is committed to helping people smoke less, stop smoking, and stay smoke-free. This pamphlet provides information about nicotine replacement therapy options such as the nicotine patch, nicotine gum, nicotine lozenges, and nicotine inhaler.
Responsibility
Prepared by: Mental Health & Addictions, Respiratory Therapy, Pharmacy Services, Occupational Health Safety & Wellness
Pamphlet Number
2145
Less detail

Aripiprazole (Abilify, Abilify Maintena)

https://libcat.nshealth.ca/en/permalink/chpams35626
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1627
Available Online
View Pamphlet
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Aripiprazole
Subjects (LCSH)
Antipsychotic drugs
Specialty
Medications
Abstract
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1627
Less detail

Risperidone (Risperdal, Risperdal Consta)

https://libcat.nshealth.ca/en/permalink/chpams35648
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1639
Available Online
View Pamphlet
Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Risperidone
Subjects (LCSH)
Antipsychotic drugs
Specialty
Medications
Abstract
Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1639
Less detail

Olanzapine (Zyprexa, Zyprexa Zydis)

https://libcat.nshealth.ca/en/permalink/chpams35690
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1669
Available Online
View Pamphlet
Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Antipsychotic Agents
Bipolar Disorder - drug therapy
Schizophrenia - drug therapy
Subjects (LCSH)
Antipsychotic drugs
Manic-depressive illness
Schizophrenia--Treatment
Specialty
Medications
Abstract
Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1669
Less detail

11 records – page 1 of 1.